key: cord-1041926-1ya5shdq authors: Lavie, Carl J.; Sanchis-Gomar, Fabian; Lippi, Giuseppe title: Cardiac Injury in COVID-19–Echoing Prognostication date: 2020-11-03 journal: J Am Coll Cardiol DOI: 10.1016/j.jacc.2020.08.068 sha: a6bf9069395c92dc75189a9552a0488c4bb797bd doc_id: 1041926 cord_uid: 1ya5shdq [Figure: see text] Cardiac magnetic resonance (CMR) revealed the presence of abnormal CMR findings (i.e., raised myocardial native T 1 , raised myocardial native T 2 , myocardial late gadolinium enhancement, and pericardial enhancement) in 78% of cases and myocardial inflammation in 60%. During hospitalization, highsensitivity cardiac troponin T (hs-cTnT) levels were found to be significantly increased (13.9 ng/l or even higher) in 15 patients (15%) whereas, at the time of performing CMR, detectable levels of hs-cTnT (i.e., $3 ng/l) were found in the vast majority of patients (i.e., 71%) recently recovered from COVID-19, with some of them displaying even values of $13.9 ng/l. Importantly, hs-cTnT values were predictive of some CMR abnormalities. In the paper published by Giustino et al. (12) Acute infection and myocardial infarction Prognostic impact of high sensitive troponin T in patients with influenza virus infection: a retrospective analysis A novel coronavirus from patients with pneumonia in China Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis The impact of 2019 novel coronavirus on heart injury: a systematic review and meta-analysis Acute myocardial injury in patients hospitalized with COVID-19 infection: a review COVID-19) severity: a meta-analysis Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) Characterization of myocardial injury in patients with COVID-19 Healthy weight and obesity prevention: JACC Health Promotion Series Obesity and outcomes in COVID-19: when an epidemic and pandemic collide Obesity is associated with more critical illness in COVID-19 Highsensitivity cardiac troponin can be an ally in the fight against COVID-19 The role of hand-held ultrasound for cardiopulmonary assessment during a pandemic. Prog Cardiovasc Dis KEY WORDS COVID-19, echocardiography, inflammation, myocaardial injury, SARS-CoV-2, troponin